Using machine learning to identify heart disease risk in childhood cancer survivors
Machine Learning-Based Identification of Cardiomyopathy Risk in Childhood Cancer Survivors
This study is looking at how smart computer programs can help doctors find heart problems earlier in childhood cancer survivors who have had certain treatments, so they can get better care and stay healthier.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10878937 on NIH RePORTER |
What this research studies
This research investigates how machine learning can enhance the identification of cardiomyopathy risk in survivors of childhood cancer, particularly those who have undergone treatment with anthracycline chemotherapy and chest radiation. The study aims to improve upon traditional 2D echocardiography methods, which can be limited by variability and sensitivity issues. By leveraging advanced AI techniques, the research seeks to provide more accurate and earlier detection of heart issues, potentially leading to better management and outcomes for these patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are childhood cancer survivors who have received anthracycline chemotherapy or chest radiation and are at risk for cardiomyopathy.
Not a fit: Patients who have not undergone treatment for childhood cancer or those without a history of anthracycline use or chest radiation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection and intervention for heart disease in childhood cancer survivors, improving their long-term health outcomes.
How similar studies have performed: Previous research has shown promise in using machine learning for similar applications in cardiology, indicating potential for success in this novel approach.
Where this research is happening
Seattle, United States
- Fred Hutchinson Cancer Center — Seattle, United States (Active)
Researchers
- Principal investigator: Chow, Eric Jessen — Fred Hutchinson Cancer Center
- Study coordinator: Chow, Eric Jessen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.